THAP10: A Model for Cancer Promotion By Herpesvirus 10 (G56906)

Target Name: THAP10

NCBI ID: G56906

THAP10

Other Name(s): THA10_HUMAN | THAP domain containing 10 | THAP domain-containing protein 10

THAP10: A Model for Cancer Promotion By Herpesvirus 10

THAP10 (THA10_HUMAN), also known as human herpesvirus 10, is a member of the herpesviridae family and is considered to be a prototype of the human herpesvirus 1 (HHV-1). HHV-1 is a member of the Togaviridae family, which includes other viruses such as herpes simplex virus (HSV) and varicella-zoster virus (VZV).

THAP10 is a single-stranded DNA virus that is characterized by its ability to infect a wide range of human cells, including epithelial, muscle, and nervous tissue cells. It is also capable of infecting animals, such as mice and rabbits. THAP10 is highly persistent and can remain latent in infected cells for extended periods of time, making it difficult to completely eliminate from the body.

One of the key features of THAP10 is its ability to cause a variety of symptoms, including fever, headache, and muscle or joint pain. These symptoms are often similar to those of other viral infections, making it difficult to diagnose and treat. In addition to cause symptoms, THAP10 is also known for its ability to cause cancer in animal models.

Despite its ability to cause symptoms and promote cancer, THAP10 is generally considered to be a safe virus. The virus is found in most people and is not capable of causing serious illness in healthy individuals. However, in individuals with compromised immune systems, THAP10 can cause serious complications, such as cancer and neurological damage.

The exact mechanism by which THAP10 promotes cancer is not fully understood. However, it is thought to work by targeting and modifying the immune system, leading to an imbalance in the body that allows the virus to multiply and cause cancer.

Despite its potential as a drug target, THAP10 is still a relatively unstudied virus. There are only a few studies that have investigated its effects on human cells and animal models. In addition, because THAP10 is a type of herpesvirus, which is known for causing symptoms in individuals with weakened immune systems, it is difficult to conduct research on its effects in healthy individuals.

Despite these challenges, there is hope for the development of drugs that can effectively target THAP10 and prevent it from causing cancer. Researchers are currently working to develop new treatments for THAP10, including vaccines and antiviral drugs. These treatments are being tested in animal models to determine their effectiveness and safety.

In conclusion, THAP10 (THA10_HUMAN) is a member of the herpesviridae family and is known for its ability to cause a variety of symptoms and promote cancer in animal models. While more research is needed, there is hope for the development of drugs that can effectively target THAP10 and prevent it from causing harm.

Protein Name: THAP Domain Containing 10

The "THAP10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about THAP10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets